top of page

Patent for EU

Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes has been granted with European Union patent no EP 3 134 426 B1.

Patent EP 3 134 426 B1
Download PDF • 1.91MB


bottom of page